| Primary |
| Hiv Infection |
47.4% |
| Drug Use For Unknown Indication |
29.1% |
| Product Used For Unknown Indication |
9.6% |
| Antiretroviral Therapy |
3.5% |
| Burkitt's Lymphoma |
2.7% |
| Prophylaxis Against Hiv Infection |
2.5% |
| Acquired Immunodeficiency Syndrome |
0.8% |
| Ill-defined Disorder |
0.6% |
| Mycobacterium Avium Complex Infection |
0.5% |
| Systemic Antiviral Treatment |
0.5% |
| Diarrhoea |
0.4% |
| Insomnia |
0.4% |
| Opportunistic Infection Prophylaxis |
0.4% |
| Oral Candidiasis |
0.4% |
| Anaemia Prophylaxis |
0.3% |
| Non-small Cell Lung Cancer Stage Iv |
0.3% |
| Prophylaxis |
0.3% |
| Retroviral Infection |
0.3% |
| Candidiasis |
0.1% |
| Chemotherapy |
0.1% |
|
| Deep Vein Thrombosis |
25.0% |
| Joint Dislocation |
7.7% |
| Hydrocele |
5.8% |
| Osteonecrosis |
5.8% |
| Sepsis |
5.8% |
| Treatment Failure |
5.8% |
| Death |
4.8% |
| Pruritus |
4.8% |
| Stillbirth |
4.8% |
| Abortion Spontaneous |
3.8% |
| Trisomy 21 |
3.8% |
| Foetal Exposure During Pregnancy |
2.9% |
| Hepatotoxicity |
2.9% |
| Progressive External Ophthalmoplegia |
2.9% |
| Tracheo-oesophageal Fistula |
2.9% |
| Virologic Failure |
2.9% |
| Cardiotoxicity |
1.9% |
| Cerebral Toxoplasmosis |
1.9% |
| Dystrophia Myotonica |
1.9% |
| Electrocardiogram Qt Prolonged |
1.9% |
|
| Secondary |
| Hiv Infection |
62.5% |
| Drug Use For Unknown Indication |
6.4% |
| Burkitt's Lymphoma |
5.1% |
| Drug Exposure During Pregnancy |
4.7% |
| Antiretroviral Therapy |
4.3% |
| Product Used For Unknown Indication |
3.6% |
| Acquired Immunodeficiency Syndrome |
2.8% |
| Hiv Test Positive |
1.4% |
| Antifungal Prophylaxis |
1.1% |
| Hepatitis C |
1.0% |
| Insomnia |
0.9% |
| Prophylaxis |
0.9% |
| Human Immunodeficiency Virus Transmission |
0.8% |
| Hypertension |
0.8% |
| Factor Viii Deficiency |
0.7% |
| Maternal Exposure During Pregnancy |
0.7% |
| Antiviral Prophylaxis |
0.6% |
| Systemic Antiviral Treatment |
0.6% |
| Gastric Ulcer |
0.6% |
| Prophylaxis Against Hiv Infection |
0.5% |
|
| Progressive External Ophthalmoplegia |
23.1% |
| Osteoporosis |
7.4% |
| Vomiting |
7.4% |
| Spinal Fracture |
5.4% |
| Drug Resistance |
5.0% |
| Hepatotoxicity |
5.0% |
| Portal Hypertension |
4.1% |
| Viral Mutation Identified |
4.1% |
| Drug Exposure During Pregnancy |
3.7% |
| Virologic Failure |
3.7% |
| Osteonecrosis |
3.3% |
| Premature Baby |
3.3% |
| Pulmonary Hypertension |
3.3% |
| Renal Failure Acute |
3.3% |
| Transient Ischaemic Attack |
3.3% |
| Pruritus |
2.9% |
| Spinal Compression Fracture |
2.9% |
| Varices Oesophageal |
2.9% |
| Visual Impairment |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
|
| Concomitant |
| Hiv Infection |
75.4% |
| Burkitt's Lymphoma |
5.3% |
| Drug Use For Unknown Indication |
3.4% |
| Hepatitis C |
1.8% |
| Maternal Exposure Timing Unspecified |
1.8% |
| Acquired Immunodeficiency Syndrome |
1.3% |
| Antiretroviral Therapy |
1.2% |
| Convulsion |
1.2% |
| Factor Viii Deficiency |
1.1% |
| Insomnia |
1.0% |
| Product Used For Unknown Indication |
0.8% |
| Cytomegalovirus Infection |
0.8% |
| Diarrhoea |
0.8% |
| Mycobacterium Avium Complex Infection |
0.8% |
| Diarrhoea Infectious |
0.7% |
| Systemic Antiviral Treatment |
0.7% |
| Antiviral Prophylaxis |
0.6% |
| Asthma |
0.6% |
| Adrenal Insufficiency |
0.5% |
| Haemorrhage |
0.5% |
|
| Death |
12.8% |
| Weight Decreased |
9.3% |
| Rash Papular |
7.0% |
| Visual Disturbance |
7.0% |
| Abortion Induced |
5.8% |
| Sick Sinus Syndrome |
5.8% |
| Pneumonia |
4.7% |
| Renal Tubular Disorder |
4.7% |
| Retinal Detachment |
4.7% |
| Spinal Fracture |
4.7% |
| Drug Resistance |
3.5% |
| Hepatitis |
3.5% |
| Pain In Extremity |
3.5% |
| Premature Rupture Of Membranes |
3.5% |
| Psychotic Disorder |
3.5% |
| Spinal Compression Fracture |
3.5% |
| Stomach Mass |
3.5% |
| Suicide Attempt |
3.5% |
| Thoracic Vertebral Fracture |
3.5% |
| Blood Triglycerides Increased |
2.3% |
|
| Interacting |
| Antiretroviral Therapy |
37.9% |
| Hiv Infection |
31.0% |
| Drug Use For Unknown Indication |
10.3% |
| Chronic Obstructive Pulmonary Disease |
4.6% |
| Fungal Infection |
4.6% |
| Lung Neoplasm Malignant |
3.4% |
| Pulmonary Hypertension |
2.3% |
| Antiviral Treatment |
1.1% |
| Immunosuppression |
1.1% |
| Organic Erectile Dysfunction |
1.1% |
| Product Used For Unknown Indication |
1.1% |
| Renal Transplant |
1.1% |
|
| Drug Level Increased |
23.5% |
| Drug Interaction |
17.6% |
| Neuropathy Peripheral |
11.8% |
| Thrombocytopenia |
11.8% |
| Drug Metabolising Enzyme Test Abnormal |
5.9% |
| Herpes Simplex |
5.9% |
| Muscular Weakness |
5.9% |
| Overdose |
5.9% |
| Pain In Extremity |
5.9% |
| Transaminases Increased |
5.9% |
|
